Manufacturers Provide Improved Health Systems to Support Extracorporeal Therapies Growing incidences of acute kidney injury (AKI) have catalyzed the need for improved and quality treatment therapies in the continuous renal replacement therapy (CRRT) landscape. South East Asia and South America, individually, account for ~31% each, of the hospitalized population suffering from acute kidney injury in 2018. Read Report Overview - https://www.transparencymarketresearch.com/continuous-renal-replacement-therapy-market.html With the help of several clinical trials, continuous venovenous haemodiafiltration (CVVHDF) and the continuous venovenous heamofiltration (CVVHF) mode of therapies have helped improve the survival rates in patients suffering from sepsis-induced acute kidney injury (SAKI) Continue reading →

MannKind Corp. in Westlake Village has received its final $12.5 million milestone payment from United Therapeutics, the company said Thursday Continue reading →

This article was originally published here J Clin Hypertens (Greenwich). 2020 Nov 21. doi: 10.1111/jch.14101. Continue reading →

Release Date: November 24, 2020 BUFFALO, N.Y. If youre sitting down, the findings of two major new studies led by University at Buffalo researchers are likely to get you moving. Women who met the federal physical activity guideline of 30 minutes per day of moderate activity exclusively through walking had a significantly lower risk of developing hypertension, according to a paper published in the November issue of the American Heart Association journal Hypertension Continue reading →

CALGARY -- Albertas government is now sharing data that shows how many people who have contracted COVID-19 have underlying conditions. But health experts, including Dr. Deena Hinshaw, say Albertans have to remember the virus is not just affecting people who are older or who are sick. Continue reading →

This article was originally published here Zhonghua Yi Xue Za Zhi. Continue reading →

The research report on Global Hypertension and Heart Failure Drugs Market is a professional detailing of the important elements that drive the Hypertension and Heart Failure Drugs market growth rate and revenue statistics. Continue reading →

Patients with end-stage renal disease (ESRD) have a cardiovascular mortality about 15-30 times the general population and this is reduced by about 70% with renal transplant. Dobutamine stress echocardiography (DSE) is commonly performed for preoperative cardiac evaluation before renal transplantation. Continue reading →

Medical practitioners have been told to consider choosing antihypertensive medications with the lowest possible potential for adverse drug effects such as sexual dysfunctions among adult hypertensive men in order to attain an optimum balance between antihypertensive efficacy and adequate preservation of sexual functions. Experts in an assessment of the effect of prescribed antihypertensive medications on sexual dysfunctions in men, including decreased libido and intercourse dissatisfaction, indicate that these drugs can cause medication-induced sexual dysfunctions but to various degrees. In a new study, the highest occurrence of sexual dysfunctions was associated with calcium-channel blockers in 32 (20.1 per cent) patients, followed by diuretics in 27 (17.0 per cent) and, angiotensin-converting enzyme inhibitors in 20 (12.6 per cent) patients. Continue reading →

An informative study on the Pulmonary Arterial Hypertension (PAH) Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by making business conclusions and shape the future of the organizations. Individual analysis of top regions and countries like North America, Europe, Asia-Pacific, South America, Asia-Pacific, Middle East & Africa and Latin America and the rest of the world is conducted. Industry overview, product definitions, and growth status are presented Continue reading →